Stockreport

Kinaset Therapeutics Debuts Positive Outcomes Data from Phase 1b Study of KN-002 at the 2024 American Thoracic Society (ATS) International Conference [Yahoo! Finance]

Philip Morris International Inc  (PM) 
Last philip morris international inc earnings: 4/21 06:59 am Check Earnings Report
US:NYSE Investor Relations: pmi.com/investor-relations/overview
PDF – Outcomes support evaluation of KN-002 in patients with eosinophilic and non-eosinophilic moderate to severe asthma and chronic obstructive pulmonary disease (COPD) – [Read more]